This shows that this pathway is persistently activated in anthracycline-induced cardiomyopathy and that dysregulation might become more pronounced longer after anthracycline administration, possibly due to MMP9 secretion by invading immune cells. This evidence concerns the gene MMP9 and cardiomyopathy.